
|Videos|November 24, 2020
Chief Endpoints and Potential Significance: Phase 3b OLIKOS Trial
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
2
Linking Plasma p-tau217 to Brain Metabolism in Alzheimer Disease: Insights With Ana C. Pereira, MD
3
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
4
Bevacizumab Secures Approval in Japan as World's First Therapy for Neurofibromatosis Type 2
5































